A single-center experience in use of tocilizumab in COVID-19 pneumonia in India

BACKGROUND: IL-6 receptor antagonist tocilizumab (TCZ) has been used in several reported studies in the treatment of COVID-19 pneumonia and pieces of evidence are still emerging. METHODS: All patients with COVID-19 pneumonia showing features of hyperinflammatory syndrome receiving TCZ at a tertiary...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Med J Armed Forces India
Main Authors: Joshi, Aditya, Kumar M, Krishna, Kumar, Abhishek, Nair, Ranjith K., Singh, Jasdeep, Chakrabarti, Ritwik, Kapoor, Rajan
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8313049/
https://ncbi.nlm.nih.gov/pubmed/34334897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mjafi.2021.05.022
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados